The abstract is read at the publisher; the summary is JClub's.
Community carriage of extended-spectrum β-lactamase–producing Escherichia coli shows divergent global epidemiology, with lower prevalence in high-income countries than in low- and middle-income countries.
- Why it matters: Regional differences in carriage prevalence remain incompletely explained, limiting the ability to design targeted public health actions that match local transmission and risk patterns.
- What they did: This review integrates epidemiological, clinical, and bacterial genetic evidence, linking prevalence variation to socioeconomic indicators, antibiotic use, and differing transmission routes across human, animal, and environmental sectors.
- The result: Molecular data suggest distinct E. coli phylogroup backgrounds—A and B1 in LMICs versus B2 in HICs—supporting tailored strategies such as antibiotic stewardship to curb further increases.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.